KRISTINE KINGERY: Open Payments
NPI 1679517155 · MIDDLETON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 34 payments from 19 companies in 2025. Trend: 2023 $149 · 2024 $309 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $65 |
| Amgen Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Exeltis, USA Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
| Exact Sciences Corporation | 2 | $40 |
| ABBVIE INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
Products named: Veozah, LEQVIO, SLYND, VOQUEZNA, Cologuard Collection Kit, FARXIGA, Rybelsus, MOUNJARO.
Industry payments across ID — which companies pay providers there.
